NPCE Kronos AI forecast
A 30-trading-day price forecast for Neuropace Inc. (NPCE) from Kronos AI, an open-source foundation model trained on candlestick charts.
Kronos AI's median forecast puts Neuropace Inc. at $14.27 on 2026-12-08, +9.6% from the last close of $13.02 on 2026-10-27. Eight out of ten sampled paths end between $13.90 and $15.06, and 8 of the 8 paths finish above today's price.
Forecast path
median, with the 10–90% band of the sampled pathsOpen the interactive forecast → Full analysis of NPCE
The forecast, week by week
| Date | Median | Low (10%) | High (90%) |
|---|---|---|---|
| 2026-11-03 | $13.15 | $12.95 | $13.49 |
| 2026-11-10 | $13.68 | $13.39 | $14.29 |
| 2026-11-17 | $13.81 | $13.38 | $14.23 |
| 2026-11-24 | $14.05 | $13.74 | $14.56 |
| 2026-12-01 | $14.36 | $14.00 | $14.80 |
| 2026-12-08 | $14.27 | $13.90 | $15.06 |
What is Kronos AI?
Kronos is an open-source foundation model for financial candlesticks, pre-trained on K-line data from more than 45 exchanges. Gnzub runs it on each stock's last 120 daily bars and samples several possible futures, so the forecast is a range of outcomes rather than one confident line. It is a statistical model, not an analyst: it reads price patterns only and knows nothing about news, earnings or the business.
Questions
- What is the Kronos AI forecast for NPCE?
- Kronos AI's median forecast for NPCE is $14.27 in 30 trading days, +9.6% from the last close, with a 10–90% range of $13.90 to $15.06.
- Is the NPCE Kronos forecast a buy or sell signal?
- No. It is the output of a statistical model that reads price history only. It is not investment advice, and the range shows how uncertain the model is.
- How often is the forecast updated?
- The forecasts are regenerated regularly; this one starts from the close of 2026-10-27.
Kronos forecasts for similar companies
- SYK — Stryker Corporation
- MMM — 3M Company
- BSX — Boston Scientific Corporation
- BDX — Becton Dickinson and Company
- MDLN — Medline Inc.
- RMD — ResMed Inc.